US$ 21.39
foxo4-dri human trial senolytic FOX04-DRI (10mg) – Nordsci foxo4-dri peptide senolytic human trial
Description
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Patients with a history of GI sensitivity who want proactive gut support before starting or escalating GLP-1 medication

Soft tissue healing research
This upregulation of VEGF was accompanied by the formation of angiogenic factors, highlighting the intricate interplay between vascular remodeling and neuroinflammation in EAE pathology
